Clinical decline in Alzheimer’s requires plaque and proteins
Monday, April 23, 2012 - 19:30
in Health & Medicine
The neuron-killing pathology of Alzheimer’s disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of an altered protein called p-tau.